MYM Continues Growth Plans on Australian Project

Vancouver, B.C., March 2, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce its consultant on the Australian project, Michael Horsfall, has renewed his agreement with MYM.

Mr. Horsfall is co-founder and CEO of PUF Ventures Australia Pty and Natures Hemp Australia Pty Ltd. He has worked extensively as a strategic business consultant with various Australian and Internationally listed fortune 100 companies and brings over 20 years’ experience to the role. He has been responsible for successfully leading pursuit and capture teams across Government and Whole-of-Government (WOG) IT Outsourcing Contracts for both Federal and State Governments. Mr. Horsfall has founded numerous companies in the Information Technology, Consulting, Finance, Hospitality and Real Estate sectors. He brings with him an extensive network and relationships combined with an in-depth understanding of business and Government.

“We are extremely fortunate to be working with Mr. Hosfall,” said Rob Gietl, CEO of MYM. “His experience consulting with Fortune 100 companies and navigating the various levels of Australian government will prove to be an asset in our stated goal of building a 1.2 million square foot greenhouse in Australia”.

Mr. Horsfall will be granted, effective today, 140,000 stock options (each an “Option”) of the Company in accordance with the Company’s current stock option plan. Each Option is exercisable into one common share (“a “Share”) of the Company at a price of $2.41 per Share for a period of 1 year from the vesting date. The options will vest over 27 months, with 14,000 vesting immediately and 14,000 on each three-month anniversary date thereafter.

The issuance of the Options is subject to the approval of the Canadian Stock Exchange. If the issuance of the options is approved by the Canadian Stock Exchange, the Options may be subject to a minimum hold period of 4 months and one day in accordance with applicable securities laws.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM has two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a partner in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).


Rob Gietl, CEO
MYM Nutraceuticals Inc.

Investor Relations
Terry Brown
[email protected]